English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/72570
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Amphibian antimicrobial peptides and Protozoa: Lessons from parasites

AuthorsRivas, Luis ; Luque-Ortega, Juan Román ; Andreu, David
Issue Date2009
PublisherElsevier
CitationBiochimica et Biophysica Acta - Biomembranes 1788 (8):1570-1581(2009)
AbstractAntimicrobial peptides (AMPs) from amphibians and other eukaryotes recognize pathogenicity patterns mostly related to differences in membrane composition between the host and a variety of bacterial, fungal and protozoan pathogens. Compared to the other two groups, protozoa are fairly neglected targets in antimicrobial chemotherapy, despite their role as causative agents for scourges such as malaria, amoebiasis, Chagas' disease or leishmaniasis. Herein we review the scarce but growing body of knowledge addressing the use of amphibian AMPs on parasitic protozoa, the adaptations of the protozoan to AMP pressure and their impact on AMP efficacy and specificity, and the current and foreseeable strategies for developing AMPs into practical therapeutic alternatives against parasitic disease.
URIhttp://hdl.handle.net/10261/72570
DOIhttp://dx.doi.org/10.1016/j.bbamem.2008.11.002
Identifiersdoi: 10.1016/j.bbamem.2008.11.002
issn: 0005-2736
Appears in Collections:(CIB) Artículos
Files in This Item:
There are no files associated with this item.
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.